Recursion Pharmaceuticals Inc
RXRX5.800USD
+0.120+2.11%
Close 08/04, 16:00（ET）Quotes delayed by 15 min
5.800USD+5.800After-hours (ET)
2.35BMarket Cap
LossP/E TTM
Recursion Pharmaceuticals Inc
5.800
+0.120+2.11%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q2
Total revenue
6.89%14.74M
-58.26%4.55M
147.62%26.08M
30.86%14.42M
13.68%13.79M
-20.36%10.89M
-19.96%10.53M
43.56%11.02M
127.53%12.13M
439.91%13.68M
419.34%13.16M
201.06%7.67M
108.16%5.33M
--2.53M
--2.53M
1270.43%2.55M
--2.56M
--186.00K
Revenue
6.89%14.74M
-58.26%4.55M
147.62%26.08M
30.86%14.42M
13.68%13.79M
-20.36%10.89M
-19.96%10.53M
43.56%11.02M
127.53%12.13M
439.91%13.68M
419.34%13.16M
201.06%7.67M
108.16%5.33M
--2.53M
--2.53M
1270.43%2.55M
--2.56M
--186.00K
Cost of revenue
95.50%21.83M
29.48%12.79M
11.05%12.08M
-1.95%9.20M
-10.30%11.17M
-8.85%9.88M
-29.41%10.88M
-34.05%9.38M
59.61%12.45M
--10.84M
--15.41M
--14.23M
--7.80M
----
----
----
----
----
Operating expenses
87.15%206.11M
71.47%188.31M
13.04%124.44M
23.97%114.96M
36.31%110.13M
47.10%109.82M
45.36%110.08M
30.49%92.73M
31.78%80.80M
10.62%74.66M
54.76%75.73M
63.45%71.06M
85.54%61.31M
--67.49M
--48.94M
136.25%43.48M
--33.05M
--18.40M
R&D expenses
102.05%129.63M
52.45%90.83M
5.84%70.50M
30.99%70.03M
37.90%64.16M
47.81%59.58M
63.41%66.61M
39.35%53.46M
43.75%46.52M
-12.36%40.31M
22.88%40.76M
29.83%38.36M
34.67%32.37M
--46.00M
--33.17M
123.10%29.55M
--24.03M
--13.24M
Depreciation, depletion, and amortization
161.23%19.33M
101.28%15.30M
25.79%9.56M
60.45%8.98M
97.23%7.40M
133.77%7.60M
154.27%7.60M
101.01%5.60M
35.16%3.75M
26.20%3.25M
16.03%2.99M
12.52%2.79M
87.82%2.78M
--2.58M
--2.58M
147.60%2.48M
--1.48M
--1.00M
Operating profit
-98.64%-191.37M
-85.76%-183.77M
1.20%-98.35M
-23.04%-100.54M
-40.30%-96.34M
-62.23%-98.93M
-59.09%-99.55M
-28.91%-81.72M
-22.66%-68.67M
6.12%-60.98M
-34.85%-62.57M
-54.88%-63.39M
-83.64%-55.98M
---64.96M
---46.40M
-124.67%-40.93M
---30.48M
---18.22M
Net non-operating interest income (expenses)
Non-operating interest income
37.30%5.56M
2.17%4.62M
-22.95%3.83M
-34.11%3.27M
-13.13%4.05M
22.81%4.52M
171.52%4.98M
660.28%4.96M
5256.32%4.66M
--3.68M
3566.00%1.83M
2148.28%652.00K
443.75%87.00K
----
--50.00K
20.83%29.00K
--16.00K
--24.00K
Non-operating interest expense
2440.00%508.00K
2226.92%605.00K
2148.00%562.00K
1415.38%394.00K
5.26%20.00K
100.00%26.00K
92.31%25.00K
85.71%26.00K
35.71%19.00K
--13.00K
-94.09%13.00K
-99.44%14.00K
-94.38%14.00K
----
--220.00K
487.09%2.50M
--249.00K
--426.00K
Special income (expenses)
-1208.33%-15.70M
----
----
----
0.00%-1.20M
--0.00
--0.00
100.00%0.00
---1.20M
--0.00
100.00%0.00
---2.80M
----
--0.00
---827.00K
----
----
----
Other non-operating income (expenses)
-491.88%-627.00K
132.55%854.00K
-137.57%-594.00K
-775.86%-392.00K
255.34%160.00K
-1365.92%-2.62M
413.31%1.58M
928.57%58.00K
-45.07%-103.00K
-717.24%-179.00K
1162.07%308.00K
---7.00K
---71.00K
--29.00K
---29.00K
----
----
---324.00K
Income before tax
-119.90%-202.65M
-84.32%-178.90M
-2.86%-95.67M
-27.81%-98.06M
-41.06%-92.15M
-68.82%-97.06M
-53.89%-93.02M
-17.03%-76.73M
-16.70%-65.33M
11.46%-57.49M
-27.45%-60.45M
-51.06%-65.56M
-82.24%-55.98M
---64.93M
---47.43M
-129.11%-43.40M
---30.72M
---18.94M
Income tax
79.72%-158.00K
100.17%7.00K
--167.00K
---523.00K
---779.00K
---4.06M
----
----
----
----
----
----
----
----
----
----
----
----
Income after tax
-121.60%-202.49M
-92.38%-178.91M
-3.04%-95.84M
-27.13%-97.54M
-39.87%-91.37M
-61.75%-93.00M
-53.89%-93.02M
-17.03%-76.73M
-16.70%-65.33M
11.46%-57.49M
-27.45%-60.45M
-51.06%-65.56M
-82.24%-55.98M
---64.93M
---47.43M
-129.11%-43.40M
---30.72M
---18.94M
Net income from continuous operations
-121.60%-202.49M
-92.38%-178.91M
-3.04%-95.84M
-27.13%-97.54M
-39.87%-91.37M
-61.75%-93.00M
-53.89%-93.02M
-17.03%-76.73M
-16.70%-65.33M
11.46%-57.49M
-27.45%-60.45M
-51.06%-65.56M
-82.24%-55.98M
---64.93M
---47.43M
-129.11%-43.40M
---30.72M
---18.94M
Net income attributable to controlling interests
-121.60%-202.49M
-92.38%-178.91M
-3.04%-95.84M
-27.13%-97.54M
-39.87%-91.37M
-61.75%-93.00M
-53.89%-93.02M
-17.03%-76.73M
-16.70%-65.33M
11.46%-57.49M
-27.45%-60.45M
-51.06%-65.56M
-82.24%-55.98M
---64.93M
---47.43M
-129.11%-43.40M
---30.72M
---18.94M
Net income attributable to common shareholders
-121.60%-202.49M
-92.38%-178.91M
-3.04%-95.84M
-27.13%-97.54M
-39.87%-91.37M
-61.75%-93.00M
-53.89%-93.02M
-17.03%-76.73M
-16.70%-65.33M
11.46%-57.49M
-27.45%-60.45M
-51.06%-65.56M
-82.24%-55.98M
---64.93M
---47.43M
-129.11%-43.40M
---30.72M
---18.94M
Basic earnings per share
-29.86%-0.50
-31.70%-0.53
22.46%-0.34
-3.17%-0.40
-13.56%-0.39
-30.45%-0.40
-25.51%-0.44
-2.53%-0.39
-3.95%-0.34
19.05%-0.31
-23.84%-0.35
-21.36%-0.38
-79.71%-0.33
---0.38
---0.28
-168.52%-0.31
---0.18
---0.12
Diluted earnings per share
-29.86%-0.50
-31.70%-0.53
22.46%-0.34
-3.17%-0.40
-13.56%-0.39
-30.45%-0.40
-25.51%-0.44
-2.53%-0.39
-3.95%-0.34
19.05%-0.31
-23.84%-0.35
-21.36%-0.38
-79.71%-0.33
---0.38
---0.28
-168.52%-0.31
---0.18
---0.12
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
